RG 7342

Drug Profile

RG 7342

Alternative Names: RG7342; RO 6806127

Latest Information Update: 13 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antipsychotics; Small molecules
  • Mechanism of Action Metabotropic glutamate receptor 5 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 23 Apr 2015 Discontinued - Phase-I for Schizophrenia (In volunteers) in USA (PO)
  • 01 Jan 2015 Roche completes a phase I trial in Schizophrenia in USA (NCT02196636)
  • 01 Jul 2014 Phase-I clinical trials in Schizophrenia (in volunteers) in USA (PO, Liquid)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top